S&P ASX All Technology

3,075.00

0.84%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Eyetech Pharmaceuticals (MM) (EYET)
Eyetech Pharmaceuticals (MM) (EYET) News

EYET

Eyetech (EYET)

Eyetech Pharmaceuticals (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EYET

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
13/11/2005	09:52	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
11/11/2005	03:30	PR Newswire (US)	Eyetech Provides Update on Status of Pending Acquisition by OSI Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
01/11/2005	09:00	PR Newswire (US)	Eyetech Reports Third Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
17/10/2005	23:30	PR Newswire (US)	Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in Dia	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
05/10/2005	23:30	PR Newswire (US)	Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients Wit	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
16/09/2005	23:15	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
22/08/2005	10:48	PR Newswire (US)	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement	NASDAQ:EYET
22/08/2005	09:45	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be Acc	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
09/08/2005	23:30	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical Achievem	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
28/07/2005	07:30	PR Newswire (US)	Eyetech Reports Second Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
19/07/2005	04:30	PR Newswire (US)	Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists	NASDAQ:EYET
16/07/2005	03:30	PR Newswire (US)	Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
22/06/2005	22:30	PR Newswire (US)	Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
22/06/2005	05:33	PR Newswire (US)	Eyetech Vision Day to Preview Future of Macugen Franchise	NASDAQ:EYET
14/06/2005	09:34	PR Newswire (US)	Eyetech to Host Vision Day on Wednesday, June 22	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
11/06/2005	07:29	Business Wire	Schaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
10/06/2005	22:31	PR Newswire (US)	Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlin	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
09/06/2005	22:30	PR Newswire (US)	Eyetech Adopts Stockholder Rights Agreement	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
25/05/2005	11:30	PR Newswire (US)	Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
24/05/2005	22:30	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
11/05/2005	08:30	PR Newswire (US)	Eyetech to Present at the 2005 UBS Global Pharmaceuticals Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
06/05/2005	07:10	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
06/05/2005	00:19	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy Les	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
03/05/2005	07:10	PR Newswire (US)	Preclinical Study Demonstrates Significance of VEGF164 in Pathological Neovascularization	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
03/05/2005	07:10	PR Newswire (US)	Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMD	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
22/04/2005	07:30	PR Newswire (US)	Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
21/04/2005	08:09	PR Newswire (US)	Eyetech Reports First Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
08/04/2005	07:30	PR Newswire (US)	Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
08/04/2005	07:30	PR Newswire (US)	Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
19/03/2005	08:15	PR Newswire (US)	Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)